Iibka sannadkii 2021 wuxuu kordhay in ka badan $1 bilyan, taasoo ka dhigaysa kororkii labaad ee ugu weynaa ee sanadlaha ah ee iibka alaabadan ka dib kobac rikoor ah oo ah 17.3% sannadkii 2020, oo inta badan ay horseedeen alaabada taageerada difaaca jirka. Iyadoo geedaha xoojiya difaaca jirka sida elderberry ay sii wadeen inay ku raaxaystaan ​​​​iibin xooggan, iibinta geedaha loogu talagalay dheefshiidka, niyadda, tamarta iyo hurdada ayaa si weyn u kortay.
Dalagyada ugu fiican ee laga helo geedaha dabiiciga ah iyo kuwa ugu muhiimsan waaashwagandhaiyo khalka tufaaxa. Kii dambe wuxuu gaaray kaalinta 3aad ee kanaalka ugu weyn isagoo helay $178 milyan oo iib ah. Tani waa 129% ka badan tii 2020. Tani waxay muujinaysaa kororka iibka khalka tufaaxa (ACV), kaas oo aan ka mid noqon 10ka iib ee ugu sarreeya ee geedaha laga iibiyo kanaalka caadiga ah sannadkii 2019.
Kanaalka dabiiciga ah ayaa sidoo kale arkaya kobac cajiib ah, iyadoo iibinta kaabisyada khalka tufaaxa ay kor u kacday 105% taasoo gaartay $7.7 milyan sanadka 2021.
"Kaabayaasha dhimista miisaanka ayaa xisaabin doona inta badan iibka asaasiga ah ee ACV sanadka 2021. Si kastaba ha ahaatee, iibinta badeecadan ACV ee diiradda saaraya caafimaadka ayaa hoos u dhici doonta 27.2% sanadka 2021, taasoo soo jeedinaysa in macaamiisha caadiga ah ay u wareegi karaan ACV sababo la xiriira faa'iidooyin kale oo suurtagal ah." ayaa lagu sharraxay qorayaasha warbixinta cadadka bisha Nofeembar ee HerbalEGram.
"Iibinta kaabisyada khalka tufaaxa ee miisaanka dhimaya ee kanaallada tafaariiqda dabiiciga ah ayaa kor u kacday 75.8% inkastoo ay hoos u dhaceen kanaallada caadiga ah."
Iibka kanaalka ugu kobaca badan ee ugu weyn waa daawooyinka dhirta lagu daro ee ay ku jiraan ashwagandha (Withania somnifera), kaasoo kor u kacay 226% sannadkii 2021 marka la barbar dhigo 2021 si uu u gaaro $92 milyan. Kororka ayaa ashwagandha ka dhigay lambarka 7aad ee liiska ugu iibsiga badan kanaalka ugu weyn. Sannadkii 2019, daawadu waxay gashay kaalinta 33aad oo keliya kanaalka.
Kanaalka dabiiciga ah, iibka ashwagandha wuxuu kor u kacay 23 boqolkiiba ilaa $16.7 milyan, taasoo ka dhigaysa iibka afraad ee ugu wanaagsan.
Sida laga soo xigtay buugga American Herbal Pharmacopoeia (AHP), isticmaalka ashwagandha ee daawada Ayurvedic wuxuu dib ugu soo laabtay waxbaristii saynisyahanka caanka ah ee Punarvasu Atreya iyo qoraalladii markii dambe sameeyay dhaqanka Ayurvedic. Magaca geedka wuxuu ka yimid Sanskrit wuxuuna la macno yahay "urta fardaha", isagoo tilmaamaya urta xooggan ee xididdada, kuwaas oo la sheegay inay urayaan sida dhididka fardaha ama kaadida.
Xididka Ashwagandha waa nooc la yiraahdo adaptogen, oo ah walax la rumeysan yahay inay kor u qaaddo awoodda jirka ee la qabsiga noocyada kala duwan ee walbahaarka.
Elderberry (Sambucus spp., Viburnum) ayaa sii wada inay kaalinta koowaad ka gasho kanaallada waaweyn iyadoo iibkeedu yahay $274 milyan sannadkii 2021. Tani waa hoos u dhac yar (0.2%) marka la barbar dhigo sannadkii 2020. Iibka Elderberry ee kanaalka dabiiciga ah ayaa hoos u dhacay, 41% marka la barbar dhigo sannadkii ka horreeyay. Xitaa dayrtan, iibka elderberry ee kanaalka dabiiciga ah ayaa dhaaftay $31 milyan, taasoo ka dhigaysa berry-ka dhirta ee lambarka 3aad ee ugu iibsiga badan.
Iibka kanaalka dabiiciga ah ee ugu kobaca badan wuxuu ahaa quercetin, oo ah flavonol laga helo tufaaxa iyo basasha, iyadoo iibku uu kor u kacay 137.8% laga bilaabo 2020 ilaa 2021 ilaa $15.1 milyan.
CBD-da laga helo xashiishadda (cannabidiol) ayaa mar kale la kulantay hoos u dhacii ugu weynaa iyadoo qiimaha qaar ka mid ah geedaha ay kor u kacaan kuwa kalena ay hoos u dhacaan. Gaar ahaan, iibka CBD ee kanaallada caadiga ah iyo kuwa dabiiciga ah ayaa hoos u dhacay 32% iyo 24%, siday u kala horreeyaan. Si kastaba ha ahaatee, kaabista CBD ee geedaha ayaa haysatay kaalinta ugu sarreysa kanaalka dabiiciga ah iyadoo iibkeedu yahay $39 milyan.
"Iibinta kanaalada dabiiciga ah ee CBD waxay noqon doontaa $38,931,696 sanadka 2021, taasoo hoos u dhacday 24% laga bilaabo ku dhawaad ​​37% sanadka 2020," ayay qoreen qorayaasha warbixinta ABC. "Iibku wuxuu u muuqdaa inuu gaaray heerkii ugu sarreeyay sanadka 2019, iyadoo macaamiishu ay ku kharash gareeyeen in ka badan $90.7 milyan alaabadan iyada oo loo marayo kanaalada dabiiciga ah. Si kastaba ha ahaatee, xitaa ka dib laba sano oo iib ah oo hoos u dhacay, iibka dabiiciga ah ee CBD sanadka 2021 ayaa weli si weyn u sarreeya. Macaamiisha ayaa ku kharash gareyn doona qiyaastii $31.3 milyan oo dheeraad ah alaabadan. Badeecadaha CBD sanadka 2021 marka la barbar dhigo 2017 - 413.4% kororka iibka sanadlaha ah."
Waxaa xiiso leh, iibinta saddexda geed ee ugu iibka badan kanaalka dabiiciga ah ayaa hoos u dhacday: marka laga reebo CBD,timirta(#2) waxay hoos u dhacday 5.7% ilaa $38 milyan, iyoelderberry(#3) waxay hoos u dhacday 41% ilaa $31.2 milyan. Hoos u dhaca ugu caansan ee kanaalka dabiiciga ah wuxuu dhacay iyadoo la adeegsanayoEchinacea-hamamelis (-40%) iyo oregano (-31%).
Iibka Echinacea ayaa sidoo kale hoos u dhacay 24% kanaalka ugu weyn, laakiin wali wuxuu ahaa $41 milyan sannadkii 2021.
Gabagabadii, qorayaasha warbixinta waxay xuseen, "Macaamiishu [...] waxay u muuqdaan inay aad u xiiseynayaan kaabisyada ku salaysan sayniska, taas oo sharxi karta kororka iibka qaar ka mid ah maaddooyinka si fiican loo bartay iyo hoos u dhaca iibka maaddada ugu caansan ee diiradda saarta caafimaadka.
"Qaar ka mid ah isbeddellada iibka ee 2021, sida hoos u dhaca iibka qaar ka mid ah maaddooyinka difaaca jirka, waxay u ekaan karaan kuwo aan macquul ahayn, laakiin xogtu waxay muujineysaa in tani ay noqon karto tusaale kale oo ku saabsan soo noqoshada caadiga ah."
Isha: HerbalEGram, Vol. 19, No. 11, Noofambar 2022. "Iibinta Kaabista Dhirta ee Mareykanka ayaa kora 9.7% sanadka 2021," T. Smith et al.